| CASE REPORT |
|
| Year : 2020 | Volume
: 7
| Issue : 2 | Page : 74-77 |
|
|
A patient with hepatic angiosarcoma and Kasabach–Merritt syndrome effectively controlled by weekly paclitaxel therapy
Sheng- Yu Hung, Tom Wei-Wu Chen
Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan
Correspondence Address:
Dr. Tom Wei-Wu Chen
Department of Oncology, National Taiwan University Hospital, No.7, Chung Shan S. Rd., Zhongzheng Dist., Taipei 10002
Taiwan
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/JCRP.JCRP_30_19
|
|
|
Angiosarcoma accounts for <2% of all soft-tissue sarcomas, and weekly paclitaxel treatment offers clinical benefits and good tolerance. Kasabach–Merritt syndrome (KMS) is a consumptive coagulopathy status associated with vascular tumors. We report a case of hepatic angiosarcoma complicated with KMS who achieved good control in about 2 months under weekly paclitaxel. We also discuss the presentation, diagnosis, and treatment of angiosarcoma with KMS and bone marrow involvement.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
